Skip to main content Accessibility help
×
Home
Hostname: page-component-99c86f546-zzcdp Total loading time: 0.137 Render date: 2021-12-02T11:14:50.757Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Article contents

Presence of 2,5-dimethoxy-4-bromoamphetamine (DOB) among samples brought for drug checking in Spain

Published online by Cambridge University Press:  23 March 2020

P. Quintana-Mathé
Affiliation:
Institut Català de la Salut ICS, EAP Raval Sud, Barcelona, Spain Associació Benestar i Desenvolupament ABD, Energy Control EC, Barcelona, Spain
M. Grifell-Guardia*
Affiliation:
Associació Benestar i Desenvolupament ABD, Energy Control EC, Barcelona, Spain Parc de Salut Mar, Institut de Neuropsiquiatria i Addiccions INAD, Barcelona, Spain Hospital del Mar Medical Research Institute IMIM, Grup de recerca en Addiccions, Barcelona, Spain
Á. Palma-Conesa
Affiliation:
Parc de Salut Mar, Institut de Neuropsiquiatria i Addiccions INAD, Barcelona, Spain Hospital del Mar Medical Research Institute IMIM, Grup de recerca en Addiccions, Barcelona, Spain
C. Gil-Lladanosa
Affiliation:
Associació Benestar i Desenvolupament ABD, Energy Control EC, Barcelona, Spain
I. Fornís-Espinosa
Affiliation:
Associació Benestar i Desenvolupament ABD, Energy Control EC, Barcelona, Spain
F. Caudevilla-Galligo
Affiliation:
Associació Benestar i Desenvolupament ABD, Energy Control EC, Barcelona, Spain
L. Gallindo-Guarin
Affiliation:
Parc de Salut Mar, Institut de Neuropsiquiatria i Addiccions INAD, Barcelona, Spain Hospital del Mar Medical Research Institute IMIM, Grup de recerca en Addiccions, Barcelona, Spain Universitat Autònoma de Barcelona UAB, Bellaterra, Spain
M. Farre-Albaladeo
Affiliation:
Universitat Autònoma de Barcelona UAB, Bellaterra, Spain Hospital Universitari Germans Trías i Pujol, Farmacologia Clínica, Barcelona, Spain
M. Ventura-Vilamala
Affiliation:
Associació Benestar i Desenvolupament ABD, Energy Control EC, Barcelona, Spain Hospital del Mar Medical Research Institute IMIM, Grup de recerca en Addiccions, Barcelona, Spain
M. Torrens-Melich
Affiliation:
Parc de Salut Mar, Institut de Neuropsiquiatria i Addiccions INAD, Barcelona, Spain Hospital del Mar Medical Research Institute IMIM, Grup de recerca en Addiccions, Barcelona, Spain Universitat Autònoma de Barcelona UAB, Bellaterra, Spain
*
*Corresponding author.
Get access

Abstract

Introduction

New Psychoactive Substances (NPS) appear to be increasing in popularity because they mimic the effect of traditional drugs. DOB is a world-wide controlled phenethylamine, with agonist activity in 5HT2A receptors. Its effects are comparable to those of LSD, with dosage range 1.0–3.0 mg and duration 18–30 h.

Objective

To assess the presence of DOB in the substances submitted to, and analyzed by, energy control.

Materials and methods

All samples presented to Energy Control (EC) from August 2009 to August 2015 were analyzed. EC is a spanish harm-reduction non governmental organization that offers to users the possibility of analyzing the substances they intend to consume. Samples in which DOB was detected using gas chromatography-mass spectrometry were selected for this study.

Results

From a total of 20,062 samples, 13 contained DOB (0,06%), with no clear variations among the years studied. The samples were mostly sold as DOC(8), DOB(2) and LSD(2). Nine out of total 13 samples presented as blotter.

Conclusion

Results suggest that availability of DOB in the Spanish drug market is anecdotic. Nonetheless, a number of the samples containing DOB were not sold as such, increasing the possibility of side effects, as users may ignore which substance they are actually using. When a patient presents at an Emergency Department with persistent hallucinogenic symptomatology after ingesting a blotter, psychiatrist should be aware of long-lasting psychedelics such as DOB.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EW237
Copyright
Copyright © European Psychiatric Association 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Submit a response

Comments

No Comments have been published for this article.

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Presence of 2,5-dimethoxy-4-bromoamphetamine (DOB) among samples brought for drug checking in Spain
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Presence of 2,5-dimethoxy-4-bromoamphetamine (DOB) among samples brought for drug checking in Spain
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Presence of 2,5-dimethoxy-4-bromoamphetamine (DOB) among samples brought for drug checking in Spain
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *